MYRX - Myrexis, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue--185
Cost of Revenue---
Gross Profit--185
Operating Expenses
Research Development46514,23022,296
Selling General and Administrative11,52617,57118,339
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-11,991-31,801-40,450
Income from Continuing Operations
Total Other Income/Expenses Net3705921,742
Earnings Before Interest and Taxes-11,621-31,209-38,708
Interest Expense---
Income Before Tax-11,621-31,209-38,708
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-11,621-31,209-38,708
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-11,621-31,209-38,708
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-11,621-31,209-38,708